Journal Information
Vol. 41. Issue 11.
Pages 641 (November 2005)
Vol. 41. Issue 11.
Pages 641 (November 2005)
Letters to the Editor
Full text access
Corticosteroids in Exacerbations of Chronic Obstructive Pulmonary Disease: Yes, but Less
Visits
3691
H. Verea-Hernández
Servicio de Neumología, Hospital Juan Canalejo, La Coruña, Spain
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
M Carrera, E Sala, BG Cosío, AG Agustí.
Tratamiento hospitalario de los episodios de agudización de la EPOC. Una revisión basada en la evidencia.
Arch Bronconeumol, 41 (2005), pp. 220-229
[2]
L Davies, RM Angus, PMA Calverley.
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised trial.
Lancet, 354 (1999), pp. 456-460
[3]
SD Aaron, KL Vandemheen, P Hebert, R Dales, IG Stiell, J Ahuja, et al.
Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.
N Engl J Med, 348 (2003), pp. 2618-2625
[4]
LJ Walsh, CA Wong, J Oborne, S Cooper, M Pringue, R Hubbard, et al.
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.
Thorax, 56 (2001), pp. 279-284
[5]
CE Bolton, AA Ionescu, KM Shiels, RJ Pettit, PH Edwards, MD Stone, et al.
Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 170 (2004), pp. 1286-1293
[6]
F de Vries, TP van Staa, MS Bracke, C Cooper, HG Leufkens, JW Lammers.
Severity of obstructive airway disease and risk of osteoporotic fractures.
Eur Respir J, 25 (2005), pp. 879-884
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)